Related Experiment Videos
Characterisation of the human CD30 ligand gene structure
1Department of Biochemistry, University of Western Australia, Nedlands.
Biochimica Et Biophysica Acta
|February 12, 1998
Summary
Researchers cloned and sequenced the human CD30 ligand (CD30L) gene, revealing its structure and regulatory elements. The TATA-less promoter suggests unique gene expression control mechanisms for CD30L.
Area of Science:
- Molecular Biology
- Genomics
- Immunology
Background:
- CD30 ligand (CD30L) plays a crucial role in immune regulation and T-cell activation.
- Understanding the genetic regulation of CD30L is essential for deciphering immune responses.
Purpose of the Study:
- To molecularly clone, sequence, and characterize the human CD30L gene.
- To identify regulatory elements within the 5' flanking region of the CD30L gene.
Main Methods:
- Molecular cloning of the human CD30L gene.
- DNA sequencing of the gene and its 5' flanking region.
- Bioinformatic analysis to identify regulatory sequences.
Main Results:
- The human CD30L gene comprises four exons and three introns spanning 17.1 kb.
- The 5' flanking region contains a poly-dT element and consensus binding sites for transcription factors (AP4, IK2, MZF1, E47, ELK/cETS1).
- A canonical TATA motif is absent, indicating a TATA-less promoter.
Conclusions:
- The characterized structure and regulatory elements provide insights into CD30L gene expression.
- The TATA-less promoter suggests a distinct mechanism for regulating CD30L transcription, potentially involving the identified transcription factor binding sites.